P-45 An open-label, phase 2 study of patritumab deruxtecan in patients with previously treated advanced/metastatic colorectal cancer

詳細情報 詳細情報について

• CRID

  1873961342639168768

• DOI

  10.1016/j.annonc.2021.05.100

• ISSN

  09237534

• データソース種別

  • OpenAIRE